4.5 Article

3-aminobenzamide protects against colitis associated diabetes mellitus in male BALB/c mice: Role of PARP-1, NLRP3, SIRT-1, AMPK

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Association of Type 1 diabetes with ulcerative colitis in BALB/c mice: Investigations on sex-specific differences

Shivani Singla et al.

Summary: The study found that hyperglycemic conditions exacerbated the pathological conditions in UC of male animals, while milder conditions developed in females.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2022)

Article Pharmacology & Pharmacy

Intervention of 3-aminobenzamide against Dextran Sulphate Sodium induced colitis in mice: Investigations on molecular mechanisms

Shivani Singla et al.

Summary: The study demonstrates the protective effect of 3-aminobenzamide in ulcerative colitis by modulating various molecular targets and restoring intestinal integrity. Lower doses of 3-aminobenzamide show more prominent protective effects against ulcerative colitis than higher doses.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway

Shuai Peng et al.

Summary: The PARP-1 inhibitor 5-AIQ demonstrates significant pharmacological effects in a mouse model of colitis by reducing tissue damage and inflammation, modulating immune balance, and downregulating key components of signaling pathways.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Endocrinology & Metabolism

PARP-1 and SIRT-1 are Interacted in Diabetic Nephropathy by Activating AMPK/PGC-1 alpha Signaling Pathway

Hengmei Zhu et al.

Summary: This study investigated the interplay between PARP-1 and SIRT-1 in diabetic nephropathy (DN) through the AMPK/PGC-1 alpha signaling pathway. Results showed that PARP-1 and ECM marker FN were upregulated while SIRT-1 was downregulated in DN, and their levels were restored by specific treatments. Activation of the AMPK-PGC-1 alpha pathway may offer a potential therapeutic method for DN.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)

Review Medicine, Research & Experimental

New Therapeutics for Ulcerative Colitis

Robert P. Hirten et al.

Summary: This review explores novel therapeutic approaches to UC, including promising drugs, efforts to maximize the efficacy of currently available treatment options, and non-medication-based modalities. Treatment approaches which show promise in impacting the future of UC management are highlighted.

ANNUAL REVIEW OF MEDICINE, VOL 72, 2021 (2021)

Article Biochemistry & Molecular Biology

PARP1 deficiency protects against hyperglycemia-induced neointimal hyperplasia by upregulating TFPI2 activity in diabetic mice

Zhao-yang Wang et al.

Summary: The study indicates that PARP1 plays a crucial role in diabetic neointimal hyperplasia by promoting VSMCs proliferation and migration through downregulating TFPI2, thereby accelerating the development of occlusive disorders associated with diabetes.

REDOX BIOLOGY (2021)

Article Cell Biology

Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells

Dominika Kovacs et al.

Summary: The study showed that the PARP inhibitor olaparib improved experimental Crohn's disease by reducing inflammation, enhancing barrier integrity, and regulating cytokine levels. In both the TNBS-induced mouse colitis model and Caco-2 monolayer culture, olaparib demonstrated anti-inflammatory and protective effects on the epithelial barrier.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Pharmacology & Pharmacy

Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets

Anderson dos Santos Ramos et al.

Summary: Neutrophils, particularly their ability to form extracellular traps (NETs), play a significant role in the pathophysiology of inflammatory bowel disease (IBD). Studies have shown increased levels of NETs in tissue and serum samples from IBD patients, indicating their involvement in disease progression. This highlights the potential of targeting NETs as a therapeutic strategy to expand the current spectrum of IBD therapies.

PHARMACOLOGICAL RESEARCH (2021)

Review Geriatrics & Gerontology

Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine

Ying Bai et al.

Summary: The NLRP3 inflammasome plays a vital role in the progression of diabetes and its complications, while natural herbal medicine can ameliorate symptoms and delay progression due to its anti-inflammatory and anti-oxidative properties. Understanding the relationship between inflammation and metabolic disorders through natural compounds targeting NLRP3 inflammasome sheds light on potential therapies for treating diabetes and its complications.

AGING AND DISEASE (2021)

Editorial Material Gastroenterology & Hepatology

Evolving therapeutic goals in ulcerative colitis: towards disease clearance

Silvio Danese et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

Zinc deficient diet increases the toxicity of bisphenol A in rat testis

Chittaranjan Sahu et al.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)

Article Endocrinology & Metabolism

Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development

Siddhartha S. Ghosh et al.

JOURNAL OF THE ENDOCRINE SOCIETY (2020)

Article Medicine, General & Internal

Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis Patients

Yue Tan et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)

Article Multidisciplinary Sciences

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Christoph A. Thaiss et al.

SCIENCE (2018)

Article Oncology

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1 alpha axis

Maayan Waldman et al.

EXPERIMENTAL CELL RESEARCH (2018)

Review Gastroenterology & Hepatology

The emerging role of histologic disease activity assessment in ulcerative colitis

Rish K. Pai et al.

GASTROINTESTINAL ENDOSCOPY (2018)

Editorial Material Multidisciplinary Sciences

ULCERATIVE COLITIS: TOWARDS REMISSION

Michael Eisenstein

NATURE (2018)

Review Immunology

New treatment strategies for ulcerative colitis

Julian Panes et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)

Article Cell Biology

Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage

Xiang Kong et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Article Biotechnology & Applied Microbiology

A standard tissue as a control for histochemical and immunohistochemical staining

D. Otali et al.

BIOTECHNIC & HISTOCHEMISTRY (2016)

Article Multidisciplinary Sciences

NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets

Changyun Hu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Biochemistry & Molecular Biology

Zinc protects cyclophosphamide-induced testicular damage in rat: Involvement of metallothionein, tesmin and Nrf2

Krishna Prahlad Maremanda et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Article Gastroenterology & Hepatology

Glucose intolerance and diabetes mellitus in ulcerative colitis: Pathogenetic and therapeutic implications

Giovanni Maconi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Biotechnology & Applied Microbiology

Telmisartan ameliorates germ cell toxicity in the STZ-induced diabetic rat: Studies on possible molecular mechanisms

S. Kushwaha et al.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2013)

Letter Gastroenterology & Hepatology

Differential expression of occludin in patients with ulcerative colitis and healthy controls

Jesus K. Yamamoto-Furusho et al.

INFLAMMATORY BOWEL DISEASES (2012)

Review Gastroenterology & Hepatology

Ulcerative colitis as a progressive disease: The forgotten evidence

Joana Torres et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Medicine, General & Internal

Western Blot: Technique, Theory, and Trouble Shooting

Tahrin Mahmood et al.

NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2012)

Article Gastroenterology & Hepatology

Epithelial apoptosis: Cause or consequence of ulcerative colitis?

Jakob Benedict Seidelin et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)

Article Pharmacology & Pharmacy

Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice

K. Amirshahrokhi et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)

Article Biochemical Research Methods

Immunofluorescence in brain sections: simultaneous detection of presynaptic and postsynaptic proteins in identified neurons

Edith M. Schneider Gasser et al.

NATURE PROTOCOLS (2006)

Article Biochemistry & Molecular Biology

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update

C Soldani et al.

APOPTOSIS (2002)

Article Gastroenterology & Hepatology

Inhibition of poly( ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis

HB Jijon et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)